Tilray Brands, Inc.
TLRY$1.30B
Small CapNASDAQMedicinal Chemicals & Botanical ProductsCannabis🇺🇸North AmericaNEW YORK1.6K employees
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand,Latin America, with growing facilities in Germany, Portugal and the United Kingdom.
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Jul 27, 2026
5wMarket Overview
Stock performance and key metrics
TLRY News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
High THC/Low CBD Cannabis | Phase 2 | Posttraumatic Stress Disorder | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply